Hims & Hers Health Inc is a household & personal products business based in the US. Hims-and-Hers Health shares (HIMS) are listed on the NYSE and all prices are listed in US Dollars. Hims-and-Hers Health employs 181 staff and has a trailing 12-month revenue of around 0.00.
How to buy shares in Hims-and-Hers Health
- Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – HIMS – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Hims-and-Hers Health stock price (NYSE: HIMS)Use our graph to track the performance of HIMS stocks over time.
Hims-and-Hers Health shares at a glance
|Latest market close||$7.77|
|52-week range||$6.71 - $25.40|
|50-day moving average||$8.11|
|200-day moving average||$9.82|
|Wall St. target price||$11.75|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-0.49|
Buy Hims-and-Hers Health shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Hims-and-Hers Health stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Hims-and-Hers Health price performance over time
|1 week (2021-10-16)||N/A|
|1 month (2021-09-24)||-4.07%|
|3 months (2021-07-27)||-5.24%|
|6 months (2021-04-27)||-35.52%|
|1 year (2020-10-27)||-22.92%|
|2 years (2019-10-25)||-21.12%|
|3 years (2018-10-23)||N/A|
|5 years (2016-10-23)||N/A|
Hims-and-Hers Health financials
|Revenue TTM||$195.8 million|
|Gross profit TTM||$109.5 million|
|Return on assets TTM||-20.39%|
|Return on equity TTM||-37.49%|
|Market capitalisation||$1.5 billion|
TTM: trailing 12 months
Shorting Hims-and-Hers Health shares
There are currently 6.4 million Hims-and-Hers Health shares held short by investors – that's known as Hims-and-Hers Health's "short interest". This figure is 15.3% up from 5.6 million last month.
There are a few different ways that this level of interest in shorting Hims-and-Hers Health shares can be evaluated.
Hims-and-Hers Health's "short interest ratio" (SIR)
Hims-and-Hers Health's "short interest ratio" (SIR) is the quantity of Hims-and-Hers Health shares currently shorted divided by the average quantity of Hims-and-Hers Health shares traded daily (recently around 2.5 million). Hims-and-Hers Health's SIR currently stands at 2.54. In other words for every 100,000 Hims-and-Hers Health shares traded daily on the market, roughly 2540 shares are currently held short.
To gain some more context, you can compare Hims-and-Hers Health's short interest ratio against those of similar companies.
However Hims-and-Hers Health's short interest can also be evaluated against the total number of Hims-and-Hers Health shares, or, against the total number of tradable Hims-and-Hers Health shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Hims-and-Hers Health's short interest could be expressed as 0.03% of the outstanding shares (for every 100,000 Hims-and-Hers Health shares in existence, roughly 30 shares are currently held short) or 0.0605% of the tradable shares (for every 100,000 tradable Hims-and-Hers Health shares, roughly 61 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Hims-and-Hers Health.
Find out more about how you can short Hims-and-Hers Health stock.
Hims-and-Hers Health share dividends
We're not expecting Hims-and-Hers Health to pay a dividend over the next 12 months.
You may also wish to consider:
- Humana (HUM.US) (0.58% forward annual dividend yield)
Hims-and-Hers Health overview
Hims & Hers Health, Inc. operates a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals. The company offers a range of health and wellness products and services available for purchase on its websites directly by customers. It provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, as well as cosmetics and supplement products, primarily focusing on wellness, sexual health, skincare, and hair care. The company's curated non-prescription products include vitamin C, melatonin, collagen protein, biotin, and teas in the wellness category; moisturizer, fragrances, face wash, and anti-wrinkle creams in the skincare category; condoms and lubricants in the sexual health category; and shampoos, conditioners, scalp scrubs, and topical treatments, such as minoxidil in the hair care category. It also offers medical consultation services; and engages in the wholesale of non-prescription product sales to retailers. Hims & Hers Health, Inc.
Hims-and-Hers Health in the news
Hims & Hers Health, Inc. to Announce Third Quarter 2021 Financial Results and Host Conference Call
Regis Corporation Names John Davi as Chief Technology Officer
This Under-the-Radar Healthcare Stock Might Be on Sale for the Last Time
Frequently asked questionsWhat percentage of Hims-and-Hers Health is owned by insiders or institutions?
Currently 18.54% of Hims-and-Hers Health shares are held by insiders and 56.452% by institutions. How many people work for Hims-and-Hers Health?
Latest data suggests 181 work at Hims-and-Hers Health. When does the fiscal year end for Hims-and-Hers Health?
Hims-and-Hers Health's fiscal year ends in December. Where is Hims-and-Hers Health based?
Hims-and-Hers Health's address is: 2269 Chestnut Street, San Francisco, CA, United States, 94123 What is Hims-and-Hers Health's ISIN number?
Hims-and-Hers Health's international securities identification number is: US4330001060
More guides on Finder
How to buy ProShares Bitcoin Strategy ETF (BITO)
Steps to owning and managing ProShares Bitcoin Strategy ETF units.
How to buy The Real Good Food Company (RGF) stock when it goes public
Everything we know about the The Real Good Food Company IPO, plus information on how to buy in.
How to buy Lulu’s Fashion Lounge Holdings (LVLU) stock when it goes public
Everything we know about the Lulu’s Fashion Lounge Holdings IPO, plus information on how to buy in.
How to buy Allarity Therapeutics (ALLR) stock when it goes public
Everything we know about the Allarity Therapeutics IPO, plus information on how to buy in.
How to buy Jupiter Neurosciences (JUNS) stock when it goes public
Everything we know about the Jupiter Neurosciences IPO, plus information on how to buy in.
How to buy Mainz Biomed (MYNZ) stock when it goes public
Everything we know about the Mainz Biomed IPO, plus information on how to buy in.
How to buy Progressive Care stock when it goes public
Everything we know about the Progressive Care IPO, plus information on how to buy in.
How to buy Desert Peak Minerals (DPM) stock when it goes public
Everything we know about the Desert Peak Minerals IPO, plus information on how to buy in.
How to buy Vaxxinity (VAXX) stock when it goes public
Everything we know about the Vaxxinity IPO, plus information on how to buy in.
How to buy Entrada Therapeutics (TRDA) stock when it goes public
Everything we know about the Entrada Therapeutics IPO, plus information on how to buy in.
Ask an Expert